<DOC>
	<DOCNO>NCT00437619</DOCNO>
	<brief_summary>This single arm study evaluate efficacy safety sequential treatment Diavobet ( betamethasone propionate 0.5mg/g plus calcipotriol hydrate 50 micrograms/g ) daily 4 week follow Daivonex ( calcipotriol hydrate 50 micrograms/g ) twice daily 4 week , control sign symptoms patient mild moderate psoriasis . Only patient show &gt; 50 % response Daivobet progress Daivonex maintenance phase . The anticipated time study treatment &lt; 3 month , target sample size 100-500 individual .</brief_summary>
	<brief_title>A Study Sequential Treatment With Daivobet ( Betamethasone Dipropionate Plus Calcipotriol ) Daivonex ( Calcipotriol ) Patients With Psoriasis .</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Calcipotriene</mesh_term>
	<mesh_term>Calcitriol</mesh_term>
	<criteria>adult patient &gt; =18 year age ; clinical diagnosis psoriasis vulgaris ; PASI score 112 &gt; =1 body area . clinical presentation erythrodermic pustular psoriasis , express plate localize lesion face and/or scalp ; viral , fungal bacterial skin infection ; use topical treatment psoriasis within previous 15 day ; use systemic therapy phototherapy psoriasis within previous 30 day .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>